ATE533769T1 - Als kinaseinhibitoren geeignete pyrrolotriazinverbindungen - Google Patents

Als kinaseinhibitoren geeignete pyrrolotriazinverbindungen

Info

Publication number
ATE533769T1
ATE533769T1 AT06785985T AT06785985T ATE533769T1 AT E533769 T1 ATE533769 T1 AT E533769T1 AT 06785985 T AT06785985 T AT 06785985T AT 06785985 T AT06785985 T AT 06785985T AT E533769 T1 ATE533769 T1 AT E533769T1
Authority
AT
Austria
Prior art keywords
kinase inhibitors
compounds suitable
pyrrolotriazine compounds
pyrrolotriazine
pyrrolotriazine derivative
Prior art date
Application number
AT06785985T
Other languages
English (en)
Inventor
Ashvinikumar V Gavai
Ping Chen
Derek J Norris
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE533769T1 publication Critical patent/ATE533769T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06785985T 2005-07-01 2006-06-29 Als kinaseinhibitoren geeignete pyrrolotriazinverbindungen ATE533769T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69639405P 2005-07-01 2005-07-01
US77138906P 2006-02-08 2006-02-08
PCT/US2006/025631 WO2007005630A1 (en) 2005-07-01 2006-06-29 Pyrrolotriazine compounds useful as kinase inhibitors

Publications (1)

Publication Number Publication Date
ATE533769T1 true ATE533769T1 (de) 2011-12-15

Family

ID=37137434

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06785985T ATE533769T1 (de) 2005-07-01 2006-06-29 Als kinaseinhibitoren geeignete pyrrolotriazinverbindungen

Country Status (5)

Country Link
US (1) US7402582B2 (de)
EP (1) EP1899345B1 (de)
AT (1) ATE533769T1 (de)
ES (1) ES2374751T3 (de)
WO (1) WO2007005630A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2622352C (en) * 2005-09-30 2014-05-27 Miikana Therapeutics, Inc. Substituted pyrazole compounds
AU2008262291A1 (en) * 2007-06-11 2008-12-18 Miikana Therapeutics, Inc. Substituted pyrazole compounds
ES2539620T3 (es) 2008-12-19 2015-07-02 Cephalon, Inc. Pirrolotriazina como inhibidor de ALK y de JAK2
CN106841420A (zh) * 2016-12-30 2017-06-13 广州中大南沙科技创新产业园有限公司 一种LC‑MS/MS测定大鼠血浆中Ly‑7u浓度的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60026297T2 (de) 1999-05-21 2006-11-02 Bristol-Myers Squibb Co. Pyrrolotriazin kinasehemmer
US6982265B1 (en) * 1999-05-21 2006-01-03 Bristol Myers Squibb Company Pyrrolotriazine inhibitors of kinases
US6670357B2 (en) * 2000-11-17 2003-12-30 Bristol-Myers Squibb Company Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
YU37903A (sh) 2000-11-17 2006-05-25 Bristol-Myers Squibb Company POSTUPCI LEČENJA STANJA POVEZANIH SA p38 KINAZOM I JEDINJENJA PIROLOTRIAZINA KOJA SE KORISTE KAO INHIBITORI KINAZE
KR101025675B1 (ko) * 2002-04-23 2011-03-30 브리스톨-마이어스 스큅 컴퍼니 키나제 억제제로서 유용한 피롤로-트리아진 아닐린 화합물
TWI329112B (en) 2002-07-19 2010-08-21 Bristol Myers Squibb Co Novel inhibitors of kinases
WO2004013145A1 (en) 2002-08-02 2004-02-12 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
TW200420565A (en) * 2002-12-13 2004-10-16 Bristol Myers Squibb Co C-6 modified indazolylpyrrolotriazines
US7102002B2 (en) * 2004-06-16 2006-09-05 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
US7173031B2 (en) * 2004-06-28 2007-02-06 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors

Also Published As

Publication number Publication date
US7402582B2 (en) 2008-07-22
EP1899345B1 (de) 2011-11-16
WO2007005630A1 (en) 2007-01-11
EP1899345A1 (de) 2008-03-19
ES2374751T3 (es) 2012-02-21
US20070004732A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
EA200900798A1 (ru) Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы
UA101478C2 (ru) Соединения, полезные как ингибиторы raf-киназы
TW200801008A (en) Protein kinase inhibitors
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
CU20070160A7 (es) Pirrolopirazoles, inhibidores potentes de quinasa
EA200870415A1 (ru) Хиназолины для ингибирования pdk 1
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
NO20081636L (no) FAP - inhibitorer
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
JO3235B1 (ar) مركبات بيررولوبيريميدين و استعمالاتها
MA32934B1 (fr) Combinaisons inhibitrices hsp90
EA200900819A1 (ru) Хиназолины для ингибирования pdk1
ATE362932T1 (de) Azaindolverbindungen als kinaseinhibitoren
ATE482213T1 (de) Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
NO20092658L (no) New compounds
EA201070247A1 (ru) Ингибиторы протеасом
EA200970738A1 (ru) Ингибиторы активности akt
ATE497961T1 (de) Als proteinkinaseinhibitoren geeignete verbindungen
ECSP078013A (es) Inhibidores heterocíclicos de mek y métodos de uso de ellos
ATE479687T1 (de) Kinaseinhibitoren
EA200900828A1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
ATE493401T1 (de) Als proteinkinaseinhibitoren geeignete diaminotriazolverbindungen
SV2009003212A (es) Inhibidores de metaloproteasa derivados de heterociclicos ref. prd2727svpct